Cargando…

Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis

BACKGROUND: Lymphangiogenesis plays a significant role in metastasis and recurrence of gastric cancer. There is no report yet focusing on the modulation of VEGF pathway and lymphangiogenesis of gastric cancer by targeting Akt/mTOR pathway. This study aims to demonstrate the relationship between Akt/...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongxia, Guan, Runnian, Lei, Yupeng, Chen, Jianyong, Ge, Qi, Zhang, Xiaoshen, Dou, Ruoxu, Chen, Hongyuan, Liu, Hao, Qi, Xiaolong, Zhou, Xiaodong, Chen, Changyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358729/
https://www.ncbi.nlm.nih.gov/pubmed/25884175
http://dx.doi.org/10.1186/s12885-015-1109-0
_version_ 1782361287655686144
author Chen, Hongxia
Guan, Runnian
Lei, Yupeng
Chen, Jianyong
Ge, Qi
Zhang, Xiaoshen
Dou, Ruoxu
Chen, Hongyuan
Liu, Hao
Qi, Xiaolong
Zhou, Xiaodong
Chen, Changyan
author_facet Chen, Hongxia
Guan, Runnian
Lei, Yupeng
Chen, Jianyong
Ge, Qi
Zhang, Xiaoshen
Dou, Ruoxu
Chen, Hongyuan
Liu, Hao
Qi, Xiaolong
Zhou, Xiaodong
Chen, Changyan
author_sort Chen, Hongxia
collection PubMed
description BACKGROUND: Lymphangiogenesis plays a significant role in metastasis and recurrence of gastric cancer. There is no report yet focusing on the modulation of VEGF pathway and lymphangiogenesis of gastric cancer by targeting Akt/mTOR pathway. This study aims to demonstrate the relationship between Akt/mTOR pathway and VEGF-C/-D in gastric cancer. METHODS: We collected surgically resected gastric adenocarcinoma specimens from 55 consented patients. Immunohistochemistry staining of p-Akt, p-mTOR, VEGF-C, VEGF-D were performed and scored by two independent pathologists. The results were presented as staining intensity and positive staining cell rate. We also measured lymphatic vessel density (LVD) by D2-40 staining. Different dosages of p-Akt inhibitor LY294002 (12.5 μM, 25 μM, 50 μM) and p-mTOR inhibitor Rapamycin (25 nM, 50 nM, 100 nM) were given to gastric cancer cell line SGC-7901 in vitro. The inhibition rate of cell growth was tested by MTT at 24 h, 48 h and 72 h, respectively and protein expressions of Akt, p-Akt, mTOR, p-mTOR, VEGF-C and VEGF-D were examined by Western blot. RESULTS: The positive staining rates of p-Akt, p-mTOR, VEGF-C and VEGF-D in 55 gastric cancer clinical specimens were 74.54%, 85.45%, 72.73% and 58.18%. p-Akt and p-mTOR were positively correlated with VEGF-C and VEGF-D (p < 0.01). The LVD increased with incremental tendency of staining intensity of p-Akt, p-mTOR, VEGF-C and VEGF-D. LY294002 or Rapamycin significantly suppressed SGC-7901 cell growth and the inhibition rate was dose and time dependent (p < 0.001). In addition, the protein expression of p-Akt and p-mTOR were positively correlated with that of VEGF-C and VEGF-D (p < 0.05). CONCLUSIONS: The level of LVD in gastric cancer specimens was significant higher than that of normal gastric tissue and was positively correlated with p-Akt, p-mTOR, VEGF-C and VEGF-D. Inhibition of p-Akt and p-mTOR, in vitro, decreased tumor cell VEGF-C and VEGF-D significantly. Therefore, we concluded that lymphangiogenesis of gastric cancer might be related to Akt/mTOR-VEGF-C/VEGF-D axis.
format Online
Article
Text
id pubmed-4358729
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43587292015-03-14 Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis Chen, Hongxia Guan, Runnian Lei, Yupeng Chen, Jianyong Ge, Qi Zhang, Xiaoshen Dou, Ruoxu Chen, Hongyuan Liu, Hao Qi, Xiaolong Zhou, Xiaodong Chen, Changyan BMC Cancer Research Article BACKGROUND: Lymphangiogenesis plays a significant role in metastasis and recurrence of gastric cancer. There is no report yet focusing on the modulation of VEGF pathway and lymphangiogenesis of gastric cancer by targeting Akt/mTOR pathway. This study aims to demonstrate the relationship between Akt/mTOR pathway and VEGF-C/-D in gastric cancer. METHODS: We collected surgically resected gastric adenocarcinoma specimens from 55 consented patients. Immunohistochemistry staining of p-Akt, p-mTOR, VEGF-C, VEGF-D were performed and scored by two independent pathologists. The results were presented as staining intensity and positive staining cell rate. We also measured lymphatic vessel density (LVD) by D2-40 staining. Different dosages of p-Akt inhibitor LY294002 (12.5 μM, 25 μM, 50 μM) and p-mTOR inhibitor Rapamycin (25 nM, 50 nM, 100 nM) were given to gastric cancer cell line SGC-7901 in vitro. The inhibition rate of cell growth was tested by MTT at 24 h, 48 h and 72 h, respectively and protein expressions of Akt, p-Akt, mTOR, p-mTOR, VEGF-C and VEGF-D were examined by Western blot. RESULTS: The positive staining rates of p-Akt, p-mTOR, VEGF-C and VEGF-D in 55 gastric cancer clinical specimens were 74.54%, 85.45%, 72.73% and 58.18%. p-Akt and p-mTOR were positively correlated with VEGF-C and VEGF-D (p < 0.01). The LVD increased with incremental tendency of staining intensity of p-Akt, p-mTOR, VEGF-C and VEGF-D. LY294002 or Rapamycin significantly suppressed SGC-7901 cell growth and the inhibition rate was dose and time dependent (p < 0.001). In addition, the protein expression of p-Akt and p-mTOR were positively correlated with that of VEGF-C and VEGF-D (p < 0.05). CONCLUSIONS: The level of LVD in gastric cancer specimens was significant higher than that of normal gastric tissue and was positively correlated with p-Akt, p-mTOR, VEGF-C and VEGF-D. Inhibition of p-Akt and p-mTOR, in vitro, decreased tumor cell VEGF-C and VEGF-D significantly. Therefore, we concluded that lymphangiogenesis of gastric cancer might be related to Akt/mTOR-VEGF-C/VEGF-D axis. BioMed Central 2015-03-07 /pmc/articles/PMC4358729/ /pubmed/25884175 http://dx.doi.org/10.1186/s12885-015-1109-0 Text en © Chen et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chen, Hongxia
Guan, Runnian
Lei, Yupeng
Chen, Jianyong
Ge, Qi
Zhang, Xiaoshen
Dou, Ruoxu
Chen, Hongyuan
Liu, Hao
Qi, Xiaolong
Zhou, Xiaodong
Chen, Changyan
Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis
title Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis
title_full Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis
title_fullStr Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis
title_full_unstemmed Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis
title_short Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis
title_sort lymphangiogenesis in gastric cancer regulated through akt/mtor-vegf-c/vegf-d axis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358729/
https://www.ncbi.nlm.nih.gov/pubmed/25884175
http://dx.doi.org/10.1186/s12885-015-1109-0
work_keys_str_mv AT chenhongxia lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT guanrunnian lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT leiyupeng lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT chenjianyong lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT geqi lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT zhangxiaoshen lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT douruoxu lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT chenhongyuan lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT liuhao lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT qixiaolong lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT zhouxiaodong lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis
AT chenchangyan lymphangiogenesisingastriccancerregulatedthroughaktmtorvegfcvegfdaxis